Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bagshawe K. D. Cancer drug targeting. Clin Radiol. 1985 Nov;36(6):545–551. doi: 10.1016/s0009-9260(85)80230-0. [DOI] [PubMed] [Google Scholar]
- Bagshawe K. D. Third Gordon Hamilton-Fairley Memorial Lecture. Tumour markers--where do we go from here? Br J Cancer. 1983 Aug;48(2):167–175. doi: 10.1038/bjc.1983.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carl P. L., Chakravarty P. K., Katzenellenbogen J. A., Weber M. J. Protease-activated "prodrugs" for cancer chemotherapy. Proc Natl Acad Sci U S A. 1980 Apr;77(4):2224–2228. doi: 10.1073/pnas.77.4.2224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cobb L. M., Connors T. A., Elson L. A., Khan A. H., Mitchley B. C., Ross W. C., Whisson M. E. 2,4-dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256. Biochem Pharmacol. 1969 Jun;18(6):1519–1527. doi: 10.1016/0006-2952(69)90267-6. [DOI] [PubMed] [Google Scholar]
- Connors T. A., Melzack D. H. Studies on the mechanism of action of 5-aziridinyl-2,4-dinitrobenzamide (CB 1954), a selective inhibitor of the Walker tumour. Int J Cancer. 1971 Jan 15;7(1):86–92. doi: 10.1002/ijc.2910070110. [DOI] [PubMed] [Google Scholar]
- Jaffers G. J., Fuller T. C., Cosimi A. B., Russell P. S., Winn H. J., Colvin R. B. Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression. Transplantation. 1986 May;41(5):572–578. doi: 10.1097/00007890-198605000-00004. [DOI] [PubMed] [Google Scholar]
- Neuberger M. S., Williams G. T., Fox R. O. Recombinant antibodies possessing novel effector functions. Nature. 1984 Dec 13;312(5995):604–608. doi: 10.1038/312604a0. [DOI] [PubMed] [Google Scholar]
- ROSS W. C., WARWICK G. P. Reduction of cytotoxic azo compounds by hydrazine and by the xanthine oxidase-xanthine system. Nature. 1955 Aug 13;176(4476):298–299. doi: 10.1038/176298a0. [DOI] [PubMed] [Google Scholar]
- Roberts J. J., Friedlos F., Knox R. J. CB 1954 (2,4-dinitro-5-aziridinyl benzamide) becomes a DNA interstrand crosslinking agent in Walker tumour cells. Biochem Biophys Res Commun. 1986 Nov 14;140(3):1073–1078. doi: 10.1016/0006-291x(86)90744-8. [DOI] [PubMed] [Google Scholar]
- Searle F., Bier C., Buckley R. G., Newman S., Pedley R. B., Bagshawe K. D., Melton R. G., Alwan S. M., Sherwood R. F. The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitro. Br J Cancer. 1986 Mar;53(3):377–384. doi: 10.1038/bjc.1986.62. [DOI] [PMC free article] [PubMed] [Google Scholar]